91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Tumor Registry Software Supply, Demand and Key Producers, 2024-2030

Global Tumor Registry Software Supply, Demand and Key Producers, 2024-2030

Publication ID: 
GIR032403310
Publication Date: 
March 7, 2024
Pages: 
136
Publisher: 
GIR
Countries: 
Global [1]
USD 4,480.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Software [2]
IT Services [3]
Computing & Electronics [4]
Description: 

The global Tumor Registry Software market size is expected to reach $ 1489.1 million by 2030, rising at a market growth of 8.0% CAGR during the forecast period (2024-2030).
The healthcare industry, including tumor registries, is experiencing a shift towards electronic health records. Tumor registry software is being integrated with EHR systems for seamless data sharing and improved interoperability.Focus on Interoperability and Data Exchange:Interoperability remains a significant trend in tumor registry software. Efforts are being made to enhance the exchange of cancer-related data among different healthcare systems and organizations, facilitating comprehensive patient care and research.Implementation of Cancer Staging and Reporting Standards:Tumor registry software is aligning with standardized cancer staging and reporting systems. Compliance with international standards ensures consistency in data collection, analysis, and reporting, supporting collaboration in cancer research and treatment.
This report studies the global Tumor Registry Software demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tumor Registry Software, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tumor Registry Software that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tumor Registry Software total market, 2019-2030, (USD Million)
Global Tumor Registry Software total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Tumor Registry Software total market, key domestic companies and share, (USD Million)
Global Tumor Registry Software revenue by player and market share 2019-2024, (USD Million)
Global Tumor Registry Software total market by Type, CAGR, 2019-2030, (USD Million)
Global Tumor Registry Software total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Tumor Registry Software market based on the following parameters 鈥� company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include C/NET Solutions, Conduent Inc., Electronic Registry System Inc., Elekta, Himagine solutions, IBM Corporation, McKesson Corporation, NeuralFrame,Inc. and Onco Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Tumor Registry Software market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Tumor Registry Software Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Tumor Registry Software Market, Segmentation by Type
On Premise
Cloud Based
Global Tumor Registry Software Market, Segmentation by Application
Government and Third Party
Hospital and Medical Practice
Others
Companies Profiled:
C/NET Solutions
Conduent Inc.
Electronic Registry System Inc.
Elekta
Himagine solutions
IBM Corporation
McKesson Corporation
NeuralFrame,Inc.
Onco Inc.
Ordinal Data Inc.
Rocky Mountain Cancer Data Systems
Key Questions Answered
1. How big is the global Tumor Registry Software market?
2. What is the demand of the global Tumor Registry Software market?
3. What is the year over year growth of the global Tumor Registry Software market?
4. What is the total value of the global Tumor Registry Software market?
5. Who are the major players in the global Tumor Registry Software market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents: 

1 Supply Summary
1.1 Tumor Registry Software Introduction
1.2 World Tumor Registry Software Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Tumor Registry Software Total Market by Region (by Headquarter Location)
1.3.1 World Tumor Registry Software Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Tumor Registry Software Market Size (2019-2030)
1.3.3 China Tumor Registry Software Market Size (2019-2030)
1.3.4 Europe Tumor Registry Software Market Size (2019-2030)
1.3.5 Japan Tumor Registry Software Market Size (2019-2030)
1.3.6 South Korea Tumor Registry Software Market Size (2019-2030)
1.3.7 ASEAN Tumor Registry Software Market Size (2019-2030)
1.3.8 India Tumor Registry Software Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tumor Registry Software Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Tumor Registry Software Major Market Trends
2 Demand Summary
2.1 World Tumor Registry Software Consumption Value (2019-2030)
2.2 World Tumor Registry Software Consumption Value by Region
2.2.1 World Tumor Registry Software Consumption Value by Region (2019-2024)
2.2.2 World Tumor Registry Software Consumption Value Forecast by Region (2025-2030)
2.3 United States Tumor Registry Software Consumption Value (2019-2030)
2.4 China Tumor Registry Software Consumption Value (2019-2030)
2.5 Europe Tumor Registry Software Consumption Value (2019-2030)
2.6 Japan Tumor Registry Software Consumption Value (2019-2030)
2.7 South Korea Tumor Registry Software Consumption Value (2019-2030)
2.8 ASEAN Tumor Registry Software Consumption Value (2019-2030)
2.9 India Tumor Registry Software Consumption Value (2019-2030)
3 World Tumor Registry Software Companies Competitive Analysis
3.1 World Tumor Registry Software Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tumor Registry Software Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tumor Registry Software in 2023
3.2.3 Global Concentration Ratios (CR8) for Tumor Registry Software in 2023
3.3 Tumor Registry Software Company Evaluation Quadrant
3.4 Tumor Registry Software Market: Overall Company Footprint Analysis
3.4.1 Tumor Registry Software Market: Region Footprint
3.4.2 Tumor Registry Software Market: Company Product Type Footprint
3.4.3 Tumor Registry Software Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Tumor Registry Software Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tumor Registry Software Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Tumor Registry Software Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Tumor Registry Software Consumption Value Comparison
4.2.1 United States VS China: Tumor Registry Software Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Tumor Registry Software Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Tumor Registry Software Companies and Market Share, 2019-2024
4.3.1 United States Based Tumor Registry Software Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tumor Registry Software Revenue, (2019-2024)
4.4 China Based Companies Tumor Registry Software Revenue and Market Share, 2019-2024
4.4.1 China Based Tumor Registry Software Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tumor Registry Software Revenue, (2019-2024)
4.5 Rest of World Based Tumor Registry Software Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Tumor Registry Software Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Tumor Registry Software Revenue, (2019-2024)
5 Market Analysis by Type
5.1 World Tumor Registry Software Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 On Premise
5.2.2 Cloud Based
5.3 Market Segment by Type
5.3.1 World Tumor Registry Software Market Size by Type (2019-2024)
5.3.2 World Tumor Registry Software Market Size by Type (2025-2030)
5.3.3 World Tumor Registry Software Market Size Market Share by Type (2019-2030)
6 Market Analysis by Application
6.1 World Tumor Registry Software Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Government and Third Party
6.2.2 Hospital and Medical Practice
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Tumor Registry Software Market Size by Application (2019-2024)
6.3.2 World Tumor Registry Software Market Size by Application (2025-2030)
6.3.3 World Tumor Registry Software Market Size by Application (2019-2030)
7 Company Profiles
7.1 C/NET Solutions
7.1.1 C/NET Solutions Details
7.1.2 C/NET Solutions Major Business
7.1.3 C/NET Solutions Tumor Registry Software Product and Services
7.1.4 C/NET Solutions Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 C/NET Solutions Recent Developments/Updates
7.1.6 C/NET Solutions Competitive Strengths & Weaknesses
7.2 Conduent Inc.
7.2.1 Conduent Inc. Details
7.2.2 Conduent Inc. Major Business
7.2.3 Conduent Inc. Tumor Registry Software Product and Services
7.2.4 Conduent Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Conduent Inc. Recent Developments/Updates
7.2.6 Conduent Inc. Competitive Strengths & Weaknesses
7.3 Electronic Registry System Inc.
7.3.1 Electronic Registry System Inc. Details
7.3.2 Electronic Registry System Inc. Major Business
7.3.3 Electronic Registry System Inc. Tumor Registry Software Product and Services
7.3.4 Electronic Registry System Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Electronic Registry System Inc. Recent Developments/Updates
7.3.6 Electronic Registry System Inc. Competitive Strengths & Weaknesses
7.4 Elekta
7.4.1 Elekta Details
7.4.2 Elekta Major Business
7.4.3 Elekta Tumor Registry Software Product and Services
7.4.4 Elekta Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Elekta Recent Developments/Updates
7.4.6 Elekta Competitive Strengths & Weaknesses
7.5 Himagine solutions
7.5.1 Himagine solutions Details
7.5.2 Himagine solutions Major Business
7.5.3 Himagine solutions Tumor Registry Software Product and Services
7.5.4 Himagine solutions Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Himagine solutions Recent Developments/Updates
7.5.6 Himagine solutions Competitive Strengths & Weaknesses
7.6 IBM Corporation
7.6.1 IBM Corporation Details
7.6.2 IBM Corporation Major Business
7.6.3 IBM Corporation Tumor Registry Software Product and Services
7.6.4 IBM Corporation Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 IBM Corporation Recent Developments/Updates
7.6.6 IBM Corporation Competitive Strengths & Weaknesses
7.7 McKesson Corporation
7.7.1 McKesson Corporation Details
7.7.2 McKesson Corporation Major Business
7.7.3 McKesson Corporation Tumor Registry Software Product and Services
7.7.4 McKesson Corporation Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 McKesson Corporation Recent Developments/Updates
7.7.6 McKesson Corporation Competitive Strengths & Weaknesses
7.8 NeuralFrame,Inc.
7.8.1 NeuralFrame,Inc. Details
7.8.2 NeuralFrame,Inc. Major Business
7.8.3 NeuralFrame,Inc. Tumor Registry Software Product and Services
7.8.4 NeuralFrame,Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 NeuralFrame,Inc. Recent Developments/Updates
7.8.6 NeuralFrame,Inc. Competitive Strengths & Weaknesses
7.9 Onco Inc.
7.9.1 Onco Inc. Details
7.9.2 Onco Inc. Major Business
7.9.3 Onco Inc. Tumor Registry Software Product and Services
7.9.4 Onco Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Onco Inc. Recent Developments/Updates
7.9.6 Onco Inc. Competitive Strengths & Weaknesses
7.10 Ordinal Data Inc.
7.10.1 Ordinal Data Inc. Details
7.10.2 Ordinal Data Inc. Major Business
7.10.3 Ordinal Data Inc. Tumor Registry Software Product and Services
7.10.4 Ordinal Data Inc. Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 Ordinal Data Inc. Recent Developments/Updates
7.10.6 Ordinal Data Inc. Competitive Strengths & Weaknesses
7.11 Rocky Mountain Cancer Data Systems
7.11.1 Rocky Mountain Cancer Data Systems Details
7.11.2 Rocky Mountain Cancer Data Systems Major Business
7.11.3 Rocky Mountain Cancer Data Systems Tumor Registry Software Product and Services
7.11.4 Rocky Mountain Cancer Data Systems Tumor Registry Software Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Rocky Mountain Cancer Data Systems Recent Developments/Updates
7.11.6 Rocky Mountain Cancer Data Systems Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Tumor Registry Software Industry Chain
8.2 Tumor Registry Software Upstream Analysis
8.3 Tumor Registry Software Midstream Analysis
8.4 Tumor Registry Software Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned: 

C/NET Solutions
Conduent Inc.
Electronic Registry System Inc.
Elekta
Himagine solutions
IBM Corporation
McKesson Corporation
NeuralFrame,Inc.
Onco Inc.
Ordinal Data Inc.
Rocky Mountain Cancer Data Systems

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/gir/global-tumor-registry-software-supply-demand-and-key-producers-2024-2030

Links
[1] /countries/global[2] /software[3] /it-services[4] /computing-electronics